Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EARLY Antibiotics aDaptation in Ventilator-Acquired-Pneumonia Treatment After Implementation of a Broad-Panel Respiratory Multiplex PCR Test: A Multicenter Randomized Control Trial Conducted In Swiss Intensive Care Units. The EARLY ADAPT Study.

NCT07267624 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT07267624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EARLY Antibiotics aDaptation in Ventilator-Acquired-Pneumonia Treatment After Implementation of a Broad-Panel Respiratory Multiplex PCR Test: A Multicenter Randomized Control Trial Conducted In Swiss Intensive Care Units. The EARLY ADAPT Study.
Lead sponsor
University Hospital, Geneva
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 5, 2026
Completion date
June 30, 2028
Enrollment
170 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic, antibiotic prescribing for acute respiratory-tract infections, antibiotic stewardship, intensive care (icu), vap - ventilator associated pneumonia